Dual inhibition of MET and SRC kinase activity as a combined targeting strategy for colon cancer

Hepatocyte growth factor (HGF)/MET signaling is implicated in the development of colorectal cancer (CRC) and possesses therapeutic value for various types of cancer. However, inhibition of MET alone has been demonstrated to have limited efficacy. The present study examined the combined inhibition of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Exp Ther Med
Autores principales: Song, Na, Qu, Xiujuan, Liu, Shizhou, Zhang, Simeng, Liu, Jing, Qu, Jinglei, Zheng, Huachuan, Liu, Yunpeng, Che, Xiaofang
Formato: Artigo
Lenguaje:Inglês
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5526150/
https://ncbi.nlm.nih.gov/pubmed/28810597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2017.4692
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares